Revealed: How officials weighed vaccine dosing and myocarditis risk
Newly released documents show how decision-makers assessed evidence linking Covid vaccines to myocarditis when determining dosing intervals.
Documents released as part of the Covid papers reveal the internal discussions and evidence assessment that informed decisions about vaccine dosing intervals and myocarditis risk. The material shows how officials grappled with merging different bodies of evidence on the relationship between vaccination and myocarditis cases. The disclosure provides insight into what information was available to decision-makers during the vaccination campaign.
Covered byNZ HeraldNot covered byRNZStuff1NewsNewstalk ZBOtago Daily TimesNewsroomThe SpinoffBusinessDeskinterest.co.nz
Coverage across the news outlets we track, as at publication.
What outlets are saying
NZ Herald
Inside the Covid papers: What we were and were not told about vaccine doses and myocarditis risk
How decision-makers grappled with merging evidence on myocarditis and dosing intervals.